Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 18 studies | 30% ± 11% | |
macrophage | 15 studies | 26% ± 10% | |
non-classical monocyte | 12 studies | 29% ± 12% | |
monocyte | 9 studies | 32% ± 11% | |
fibroblast | 9 studies | 26% ± 11% | |
myeloid cell | 8 studies | 34% ± 17% | |
dendritic cell | 7 studies | 30% ± 15% | |
astrocyte | 7 studies | 28% ± 11% | |
GABAergic neuron | 6 studies | 35% ± 15% | |
oligodendrocyte | 6 studies | 27% ± 7% | |
natural killer cell | 5 studies | 21% ± 4% | |
conventional dendritic cell | 5 studies | 26% ± 14% | |
oligodendrocyte precursor cell | 5 studies | 30% ± 12% | |
interneuron | 5 studies | 30% ± 18% | |
endothelial cell | 4 studies | 26% ± 10% | |
neuron | 4 studies | 25% ± 8% | |
neutrophil | 4 studies | 23% ± 10% | |
mononuclear phagocyte | 4 studies | 27% ± 10% | |
regulatory T cell | 4 studies | 16% ± 1% | |
glutamatergic neuron | 4 studies | 51% ± 16% | |
T cell | 3 studies | 18% ± 1% | |
hematopoietic precursor cell | 3 studies | 18% ± 3% | |
lymphocyte | 3 studies | 18% ± 3% | |
alveolar macrophage | 3 studies | 38% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 4935.53 | 578 / 578 | 100% | 29.49 | 1152 / 1155 |
breast | 100% | 2452.17 | 459 / 459 | 99% | 34.47 | 1112 / 1118 |
ovary | 100% | 2979.64 | 180 / 180 | 98% | 17.14 | 422 / 430 |
brain | 98% | 1399.61 | 2595 / 2642 | 100% | 24.40 | 703 / 705 |
prostate | 100% | 2171.31 | 244 / 245 | 98% | 21.85 | 493 / 502 |
thymus | 100% | 1970.71 | 651 / 653 | 98% | 25.10 | 593 / 605 |
esophagus | 97% | 2149.21 | 1407 / 1445 | 99% | 30.44 | 182 / 183 |
uterus | 100% | 2895.78 | 170 / 170 | 96% | 20.46 | 440 / 459 |
bladder | 100% | 2995.10 | 21 / 21 | 96% | 18.35 | 483 / 504 |
intestine | 99% | 2300.46 | 959 / 966 | 94% | 18.14 | 497 / 527 |
adrenal gland | 100% | 1587.96 | 258 / 258 | 93% | 17.02 | 214 / 230 |
skin | 99% | 2111.21 | 1799 / 1809 | 93% | 21.09 | 437 / 472 |
stomach | 93% | 1383.30 | 334 / 359 | 96% | 21.44 | 275 / 286 |
kidney | 98% | 1422.30 | 87 / 89 | 89% | 21.10 | 799 / 901 |
pancreas | 79% | 647.05 | 260 / 328 | 98% | 33.00 | 174 / 178 |
liver | 89% | 879.57 | 202 / 226 | 85% | 11.44 | 346 / 406 |
adipose | 100% | 3149.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3606.24 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 4203.42 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 100% | 1532.86 | 799 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 7125.96 | 924 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 20.58 | 44 / 45 |
heart | 93% | 1293.79 | 802 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 22.56 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 64% | 8.84 | 51 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050652 | Biological process | dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process |
GO_0050650 | Biological process | chondroitin sulfate proteoglycan biosynthetic process |
GO_0030166 | Biological process | proteoglycan biosynthetic process |
GO_0030206 | Biological process | chondroitin sulfate biosynthetic process |
GO_0050653 | Biological process | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process |
GO_0050651 | Biological process | dermatan sulfate proteoglycan biosynthetic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0016020 | Cellular component | membrane |
GO_0008376 | Molecular function | acetylgalactosaminyltransferase activity |
GO_0047237 | Molecular function | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0047238 | Molecular function | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity |
Gene name | CSGALNACT2 |
Protein name | Chondroitin sulfate N-acetylgalactosaminyltransferase 2 (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2) (Beta4GalNAcT-2) (GalNAcT-2) Hexosyltransferase (EC 2.4.1.-) |
Synonyms | GALNACT2 PRO0082 CHGN2 |
Description | FUNCTION: Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). Required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains. . |
Accessions | ENST00000374466.4 [Q8N6G5-1] A0A0S2Z5K4 A0A0S2Z5F9 Q8N6G5 A0A0S2Z5F5 |